Cart
sales@molnova.com
Volagidemab
CAS No. 1233956-13-2
Volagidemab( —— )
Catalog No. M36755 CAS No. 1233956-13-2
Volagidemab, a monoclonal antibody (mAb) that antagonizes the glucagon receptor (GCGR), is utilized in researching Type 1 Diabetes (T1D) .
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 445 | Get Quote |
|
| 5MG | 687 | Get Quote |
|
| 10MG | 937 | Get Quote |
|
| 25MG | 1371 | Get Quote |
|
| 50MG | 1812 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameVolagidemab
-
NoteResearch use only, not for human use.
-
Brief DescriptionVolagidemab, a monoclonal antibody (mAb) that antagonizes the glucagon receptor (GCGR), is utilized in researching Type 1 Diabetes (T1D) .
-
DescriptionVolagidemab is an antagonistic glucagon receptor (GCGR) monoclonal antibody (mAb).Volagidemab can be used in the research of type 1 diabetes (T1D).
-
In Vitro——
-
In VivoAnimal Model:Alloxan-induced diabetic mice Dosage:5 mg/kg Administration:Subcutaneous injection (s.c.)Result:Reduced phosphorylated CREB protein and PEPCK protein expression to nondiabetic levels.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1233956-13-2
-
Formula Weight
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Pettus J, et al. Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial. Nat Med. 2022 Oct;28(10):2092-2099. ?
molnova catalog
related products
-
p-Coumaric acid
Actions Hydroxycinnamic acid found in many fruits and vegetables.
-
Sparteine
Sparteine is a natural product.
-
1,3-Dimethylpyrazole
1,3-Dimethylpyrazole is a bioactive compound isolated from Moso Bamboo Root.
